User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
(→1.4 Substrate binding site) |
(→1.4 Substrate binding site) |
||
| Line 24: | Line 24: | ||
=== 1.4 Substrate binding site === | === 1.4 Substrate binding site === | ||
| - | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/ | + | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> |
| - | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/ | + | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2'>Substrate binding site</scene> |
| - | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_ctp-a-s_mg/ | + | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_ctp-a-s_mg/2'>Substrate binding site + ligand (CTP-alpha-S) + Mg++</scene> |
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
Revision as of 12:38, 19 June 2009
Diguanylate cyclases
Contents |
1. PleD
1.1 Intro
1.2 Domain structure
1.3 Protomer
|
: , ,
1.4 Substrate binding site
|
1.5 Allosteric product binding site
|
1.5.1 C-di-GMP
1.5.2 Primary inhibition site (Ip)
1.5.3 Secondary inhibition site (Is)
1.6 Two conformations
non-activated (1w25)
activated (BeF3- modified; 2v0n)
|
|
1.7 Non-activated conformation
|
: , ,
1.8 Activated conformation
|
